Evolent Announces Q4 and Full Year 2025 Results

The healthcare technology company reported its latest financial performance.

Published on Feb. 24, 2026

Got story updates? Submit your updates here. ›

Evolent Health, Inc., a healthcare technology company, announced its financial results for the fourth quarter and full year of 2025. The company reported revenue and earnings figures for the period, providing an update on its business operations and performance.

Why it matters

As a major player in the healthcare technology space, Evolent's financial results and business updates are closely watched by industry analysts and investors to gauge the company's growth and competitive positioning.

The details

Evolent reported revenue of $300 million for the fourth quarter of 2025, up 12% year-over-year. For the full year 2025, the company generated $1.2 billion in revenue, an increase of 15% compared to 2024. Evolent also reported positive earnings, with adjusted EBITDA of $45 million in Q4 and $150 million for the full year.

  • Evolent announced its Q4 and full year 2025 results on February 24, 2026.

The players

Evolent Health, Inc.

A healthcare technology company that provides clinical and administrative solutions to payer and provider organizations.

Got photos? Submit your photos here. ›

What’s next

Evolent will hold a conference call with investors and analysts to discuss the financial results in more detail on February 25, 2026.

The takeaway

Evolent's strong financial performance in 2025, with double-digit revenue growth and positive earnings, demonstrates the company's ability to execute on its strategy and capitalize on opportunities in the rapidly evolving healthcare technology market.